abstract |
The present invention relates to methods of using triazolo-pyridazine compounds in the treatment of neuropathic pain. The invention may be used to treat mental mood disorders such as schizophrenia, anxiety, depression, bipolar disorder and panic, as well as pain, Parkinson's disease, cognitive impairment, epilepsy, circadian rhythm disorders and sleep disorders (eg shift work sleep) It also relates to the use of triazolo-pyridazine compounds in the treatment of disorders and jet lag), drug addiction, drug abuse, drug withdrawal and other diseases. The present invention also relates to novel triazolo-pyridazine compounds that selectively bind to the α 2 δ-1 subunit of the Ca channel. |